Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010; Massachusetts Medical Society; Volume: 362; Issue: 17 Linguagem: Inglês
10.1056/nejmoa1001282
ISSN1533-4406
AutoresHenry N. Ginsberg, Marshall B. Elam, Laura Lovato, John R. Crouse, Lawrence A. Leiter, Peter E. Linz, William T. Friedewald, John B. Buse, Hertzel C. Gerstein, Jeffrey L. Probstfield, Richard H. Grimm, Faramarz Ismail-Beigi, J. Thomas Bigger, David C. Goff, William C. Cushman, Denise G. Simons‐Morton, Robert P. Byington,
Tópico(s)Diabetes, Cardiovascular Risks, and Lipoproteins
ResumoWe investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease.
Referência(s)